VEGF improves survival of mesenchymal stem cells in infarcted hearts

被引:127
作者
Pons, Jennifer [2 ]
Huang, Yu [3 ]
Arakawa-Hoyt, Janice [3 ]
Washko, Daniel [3 ]
Takagawa, Junya [4 ]
Ye, Jianqin [4 ]
Grossman, William [3 ,4 ]
Su, Hua [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Anesthesia & Perioperat, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA
[4] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94110 USA
基金
美国国家卫生研究院;
关键词
MSC; Cellular stress; VEGF; Myocardial infarction; Cell engraftment;
D O I
10.1016/j.bbrc.2008.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow-derived mesenchymal stem cells (MSC) are a promising Source for cell-based treatment of myocardial infarction (MI), but existing strategies are restricted by low cell survival and engraftment. We examined whether vascular endothelial growth factor (VEGF) improve MSC viability in infracted hearts. We found long-term culture increased MSC-cellular stress: expressing more cell cycle inhibitors, p-16(INK), p21 and p19(ARF). VEGF treatment reduced cellular stress, increased pro-survival factors, phosphorylated-Akt and Bcl-xL expression and cell proliferation. Co-injection of MSCs with VEGF to MI hearts increased cell engraftment and resulted in better improvement of cardiac function than that injected with MSCs or VEGF alone. In conclusion, VEGF protects MSCs from culture-induce cellular stress and improves their viability in ischemic myocardium, which results in improvements of their therapeutic effect for the treatment of MI. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:419 / 422
页数:4
相关论文
共 23 条
[11]  
Li RK, 1997, CIRCULATION, V96, P179
[12]   Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction [J].
Mueller-Ehmsen, Jochen ;
Krausgrill, Benjamin ;
Burst, Volker ;
Schenk, Kerstin ;
Neisen, Uta C. ;
Fries, Jochen W. U. ;
Fleischmann, Bernd K. ;
Hescheler, Juergen ;
Schwinger, Robert H. G. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (05) :876-884
[13]   Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium [J].
Müller-Ehmsen, J ;
Whittaker, P ;
Kloner, RA ;
Dow, JS ;
Sakoda, T ;
Long, TI ;
Laird, PW ;
Kedes, L .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (02) :107-116
[14]   Multilineage potential of adult human mesenchymal stem cells [J].
Pittenger, MF ;
Mackay, AM ;
Beck, SC ;
Jaiswal, RK ;
Douglas, R ;
Mosca, JD ;
Moorman, MA ;
Simonetti, DW ;
Craig, S ;
Marshak, DR .
SCIENCE, 1999, 284 (5411) :143-147
[15]   Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects [J].
Shake, JG ;
Gruber, PJ ;
Baumgartner, WA ;
Senechal, G ;
Meyers, J ;
Redmond, JM ;
Pittenger, MF ;
Martin, BJ .
ANNALS OF THORACIC SURGERY, 2002, 73 (06) :1919-1925
[16]   Tumor surveillance via the ARF-p53 pathway [J].
Sherr, CJ .
GENES & DEVELOPMENT, 1998, 12 (19) :2984-2991
[17]   Expression of the p161NK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion [J].
Shibata, Kotaro R. ;
Aoyama, Tomoki ;
Shima, Yasuko ;
Fukiage, Kenichi ;
Otsuka, Sein ;
Furu, Moritoshi ;
Kohno, Yoshiki ;
Ito, Kinya ;
Fujibayashi, Shunsuke ;
Neo, Masashi ;
Nakayama, Tomitaka ;
Nakamura, Takashi ;
Toguchida, Junya .
STEM CELLS, 2007, 25 (09) :2371-2382
[18]  
Stein GH, 1999, MOL CELL BIOL, V19, P2109
[19]   Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart [J].
Toma, C ;
Pittenger, MF ;
Cahill, KS ;
Byrne, BJ ;
Kessler, PD .
CIRCULATION, 2002, 105 (01) :93-98
[20]   Beneficial hemodynamic effects of autologous bone marrow cell transplantation in rats with heart failure [J].
Tran, N ;
Bertrand, S ;
Li, Y ;
Carteaux, JP ;
Stoltz, JF ;
Villemot, JP .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) :3262-3264